AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Eglucent Kwikpen

Prescription Icon
Prescription Required

Marketer

Lupin Ltd

Salt Composition

Insulin Lispro (100IU)

Overview Eglucent Kwikpen

Rapid-acting insulin, marketed as Kwikpen Eglucent, assists in managing blood glucose for individuals with type 1 and type 2 diabetes. Its swift action lowers post-meal blood sugar, mitigating the risk of diabetes-related complications. Kwikpen Eglucent is typically administered alongside a longer-acting insulin or other diabetic medications, with subcutaneous injection technique demonstrated by your healthcare provider. Injection timing is optimal 15 minutes pre-meal or within 20 minutes of meal commencement. Discontinuation requires physician approval. Effective diabetes management necessitates adherence to a prescribed regimen including diet, exercise, and weight management as directed. Consistent blood glucose monitoring, with results shared with your physician, is crucial for dose optimization. Hypoglycemia is a prevalent side effect; precise dosing, regular monitoring, and consistent meals are preventative measures. Excessive alcohol consumption elevates hypoglycemia risk. Additional side effects may include injection site reactions (redness, swelling, lipodystrophy) and weight gain. Avoid use with existing hypoglycemia. Prior kidney, liver, or heart conditions, as well as pregnancy or breastfeeding, necessitate physician consultation regarding dosage adjustments.

Primary Ingredients of Eglucent Kwikpen

No information provided. A rephrased version cannot be created.

Uses of Eglucent Kwikpen

Managing Diabetes Mellitus

Major Benefits of Eglucent Kwikpen:

Your healthcare provider will instruct you on the proper administration of this medication.

Common Side effects of Eglucent Kwikpen:

  • Hypoglycemia (low blood glucose level)

How to use Eglucent Kwikpen:

Your healthcare provider will instruct you on the proper administration of this medication.

How Eglucent Kwikpen works:

Rapid-acting Eglucent Kwikpen insulin initiates its effects within 10 to 20 minutes post-injection. Its action mimics the body's natural insulin, promoting glucose absorption by muscle and fat tissues while concurrently suppressing hepatic glucose output.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol and Eglucent Kwikpen should not be used together.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Eglucent Kwikpen during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences to fetal development; nevertheless, data from human studies are scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Lactation and Eglucent Kwikpen use are compatible. Research in humans indicates minimal drug transfer to breast milk, posing no identified risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Eglucent Kwikpen cautiously, as dose modification may be necessary. Blood glucose should be monitored frequently to guide dosage adjustments; physician consultation is recommended.

LiverLiverCAUTION

Patients with hepatic impairment should use Eglucent Kwikpen cautiously, as dose modification may be necessary. Physician consultation is recommended. Regular blood glucose monitoring is crucial for appropriate dose management.

What if you forget to take Eglucent Kwikpen :

Omitting a dose of Eglucent Kwikpen can lead to elevated blood glucose (hyperglycemia). Monitor your blood sugar and adjust your subsequent injection accordingly.

Facts to Know About Eglucent Kwikpen

LabelValue
Chemical Category Modified insulin
Developing Habits No.
Treatment Category Diabetes Management
Action Class Fast-acting insulin analogs

FAQs on Eglucent Kwikpen

Yes, Eglucent Kwikpen is safe for pregnant individuals when prescribed by a doctor. If you are pregnant, planning pregnancy, or become pregnant while using Eglucent Kwikpen, consult your doctor immediately. They may adjust your dosage and recommend more frequent blood glucose checks.
Eglucent Kwikpen most often causes low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases if you skip meals, drink alcohol, overexert yourself, or use other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always keep a readily available source of sugar, such as candy, glucose tablets, or fruit juice, on hand.
Type 1 diabetics require lifelong Eglucent Kwikpen injections because their bodies don't produce enough insulin. Conversely, Type 2 diabetics may discontinue Eglucent Kwikpen if their diabetes is controlled through diet, exercise, and oral medication.
Store unopened Eglucent Kwikpen cartridges and pre-filled pens refrigerated (2°C to 8°C). Do not freeze. Once a cartridge is in the pen, store it at room temperature (below 30°C/86°F) and use within 28 days; discard afterwards, regardless of remaining medication.
Yes, low blood sugar (hypoglycemia) is the most common side effect of Eglucent Kwikpen. This risk increases if you miss meals, delay eating, drink alcohol, overexercise, or take other diabetes medications. Therefore, maintain consistent meal timing and portion sizes. Snack as needed after strenuous activity. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice. Regular blood sugar monitoring is crucial. Take all prescribed medications as directed and contact your doctor if you experience blood sugar fluctuations.
Before injecting, wash your hands. Select and clean an injection site as directed. Remove the pen cap and ensure the site isn't reused within a month. Attach a new needle, removing the paper tab and screwing it securely. Dial in your prescribed dose. Holding the pen at a 90-degree angle, inject the insulin. Maintain this position for 10 seconds to ensure complete delivery. Remove, unscrew, and discard the needle. Recap the pen and store it safely.
Never combine Eglucent Kwikpen with other insulins. Similarly, avoid mixing vial and cartridge insulins.
Eglucent Kwikpen is administered via subcutaneous injection. Your doctor will instruct you on the appropriate injection sites. Avoid repeated injections in the same location. Rotate injection sites among your abdomen, buttocks, thighs, and upper arms. Never inject into a muscle or vein. Change injection sites every one to two weeks, rotating within a given area before moving to another. Using the same general area for at least a week helps prevent significant blood sugar fluctuations.
To inject, first prime your pen: Holding it vertically, dial 2 units and press the dose button until a drop of insulin appears at the needle tip. For new pens, you may need to repeat this to remove all air.
Eglucent Kwikpen
934
MRP 1,029
9% off